Middle East and Africa High Throughput Screening Market

Market Introduction

High-throughput screening (HTS) is a drug discovery process that allows automated testing of large numbers of chemical and/or biological compounds for a specific biological target. High-throughput screening methods are extensively used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biological or biochemical activity of many molecules, usually drugs. They accelerate target analysis, as large-scale compound libraries can quickly be screened in a cost-effective way. HTS is a useful tool for assessing for instance pharmacological targets, pharmacologically profiling agonists and antagonists for receptors (such as GPCRs) and enzymes.

Market Overview and Dynamics

The Middle East and Africa high throughput screening market is expected to reach US$ 1,141.53 million by 2028 from US$ 763.08 million in 2021; it is estimated to register a CAGR of 5.9% from 2021 to 2028. Driving factors such as an increase in investment in research and development by the pharmaceutical and biotechnology industry and the introduction of technologically advanced products in the high throughput screening market are driving the growth of the market. However, the lack of proper automation methods is obstructing the growth of the market.

The market is witnessing the use of artificial intelligence (AI) in high-throughput screening (HTS). Using AI in HTS is an important objective of the pharmaceutical and biotech industry. Using AI-based data processing/control software, liquid handling systems, and sensitive detectors, and high-throughput screening allows a researcher to quickly conduct millions of chemicals, genetic, or pharmacological tests. Through this process, one can rapidly identify active compounds, antibodies, or genes that modulate a biomolecular pathway. Most of the top biopharmaceutical companies have started internal programs and are collaborating to develop AI platforms for increasing the research power of immuno-oncology drugs, metabolic-disease therapies, cancer treatments, and many other therapeutic targets. In July 2020, Cerevel Therapeutics—a company dedicated to research and development in neuroscience diseases therapeutics—and Cyclica—an AI-based drug discovery company—entered into a collaboration to accelerate the discovery of novel medicines in neuroscience. Cyclica’s world-class AI platform for high-throughput screening in compound identification and optimization can efficiently identify new therapeutic molecules for Cerevel Therapeutics. Such strategic developments show that AI-based high-throughput screening technologies will revolutionize drug discovery. Furthermore, there is an increase in demand for high-throughput screening owing to the need for screening new chemical entities with more efficiency, as well as ensure productive optimization of drug molecules. Technological advancements in high-throughput screening techniques and the launch of innovative systems by various market players are driving the market growth.

The Middle Eastern economy is severely affected due to the exponential growth of COVID-19 cases in the region. Since the beginning of 2020, the COVID-19 pandemic has caused enormous health, social and economic impacts, which is likely to continue in 2021. Currently, the COVID-19 diagnostic testing industry is witnessing an upsurge on account of a growing number of cases. Hence, with many laboratory and research services under acute pressure, the market for HTS is expected to be positively impacted in the region.

Key Market Segments

The Middle East and Africa high throughput screening market, based on product and service, is subsegmented into consumables, instruments, accessories, software, and services. The consumables segment is further subsegmented into reagents and assay kits and laboratory equipment. Furthermore, the instruments are further subdivided into liquid handling systems and detection systems. In 2021, the consumables segment is expected to hold the largest share of the market and is expected to register the highest CAGR during 2021–2028.

The Middle East and Africa high throughput screening market, based on the technology, is subsegmented into cell-based assays, lab-on-a-chip, ultra-high-throughput screening, bioinformatics, and label-free technology. In 2021, the cell-based assays segment is expected to hold the largest share of the market. However, the lab-on-a-chip segment is expected to register the highest CAGR during the forecast period.

The Middle East and Africa high throughput screening market, based on application, is segmented into drug discovery, biochemical screening, life sciences research, and other applications. In 2021, the drug discovery segment is expected to hold the largest share of the market and is expected to register the highest CAGR during the coming years.

The Middle East and Africa high throughput screening market, based on end user, is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CRO), and others. In 2021, the pharmaceutical and biotechnology companies segment is expected to hold the largest share of the market. However, the contract research organizations (CRO) segment is expected to register the highest CAGR during the coming years.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Middle East and Africa high throughput screening market are the South African Medical Research Council (SAMRC), Department of Science and Innovation (DSI) and Ministry of Health and Prevention (MoHAP).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa high throughput screening market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Middle East and Africa high throughput screening market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa high throughput screening market.

MIDDLE EAST AND AFRICA HIGH THROUGHPUT SCREENING MARKET SEGMENTATION

By Product and Services

• Consumables
• Instruments
• Accessories
• Software
• Services

By Technology

• Cell-Based Assays
• Lab-On-A-Chip
• Ultra-High-Throughput Screening
• Bioinformatics
• Label-Free Technology

By Application

• Drug Discovery
• Biochemical Screening
• Life Sciences Research
• Other Applications

By End User

• Pharmaceutical and Biotechnology Companies
• Academic and Government Institutes
• Contract Research Organizations (CRO)
• Others

By Country

• UAE
• South Africa
• Saudi Arabia
• Rest of Middle East and Africa

Company Profiles

• Axxam S.p.A
• Corning Incorporated
• Molecular Devices, LLC.
• Hamilton Company
• Perkin Elmer, Inc.
• THERMO FISHER SCIENTIFIC INC.
• MERCK KGaA
• Tecan Trading AG

Middle East and Africa High Throughput Screening Market Strategic Insights

Middle East and Africa High Throughput Screening Market Segmentation Analysis

Middle East and Africa High Throughput Screening Market Report Highlights

Middle East and Africa High Throughput Screening Report Scope

Middle East and Africa High Throughput Screening Market Country and Regional Insights